Tech Company Financing Transactions

Cadence Pharmaceuticals Funding Round

Cadence Pharmaceuticals, operating out of San Diego, raised $53.8 million in investment from CDIB Bioscience, Domain Associates and Frazier Healthcare Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

12481 High Bluff Dr. 200
San Diego, CA 92130
USA

Phone

(858) 436-1400

Website

www.cadencepharm.com

Email Address

[email protected]

Overview

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Theodore Schroeder

        

Chief Financial Officer

William LaRue

        

VP - General Counsel

Hazel Aker

        

VP - Human Resources

Diane Sheehan

        

VP - Regulatory Affairs

Malcolm Smith

        

VP - Sales

Scott Byrd

        

Browse more venture capital transactions:

Prev: 3/31/2006: Infinity Coding Solutions venture capital transaction
Next: 3/31/2006: Valere Power venture capital transaction

Share this article

Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary